TABLE 5.
Results of the NMA of nausea and vomiting (upper-right quarter) and grade ≥3 oral mucositis (lower-left quarter).
| CKS + CCRT | 2.51 (1.13, 5.8) | 1.03 (0.22, 4.63) | 0.84 (0.22, 3.26) | 0.94 (0.11, 7.76) | – | 2.01 (0.45, 9.40) | 0.49 (0.09, 2.19) | 2.33 (0.37, 15.57) |
|---|---|---|---|---|---|---|---|---|
| 2.73 (1.28, 10.15) | CCRT | 2.44 (0.70, 9.36) | 2.99 (1.05, 8.89) | 2.67 (0.39, 19.26) | – | 1.25 (0.35, 4.50) | 5.13 (1.45, 22.83) | 1.08 (0.20, 5.78) |
| 0.69 (0.09, 8.48) | 3.94 (0.55, 30.25) | AD + CCRT | 0.82 (0.16, 4.52) | 0.92 (0.09, 9.38) | – | 1.95 (0.33, 12.55) | 0.48 (0.07, 2.92) | 2.27 (0.28, 19.65) |
| 0.65 (0.14, 2.83) | 4.27 (1.66, 17.78) | 0.93 (0.07, 7.72) | SQFZ + CCRT | 1.12 (0.12, 10.25) | – | 2.40 (0.46, 12.86) | 0.59 (0.09, 3.00) | 2.77 (0.39, 20.37) |
| 0.39 (0.04, 5.16) | 6.98 (0.85, 67.69) | 0.56 (0.03, 10.23) | 0.61 (0.06, 8.86) | KA + CCRT | – | 2.15 (0.21, 22.30) | 0.52 (0.04, 5.18) | 2.49 (0.20, 32.56) |
| 0.78 (0.10, 9.58) | 3.57 (0.48, 27.45) | 1.11 (0.07, 19.11) | 1.19 (0.14, 15.94) | 1.96 (0.11, 41.49) | KLT + CCRT | – | – | – |
| – | – | – | – | – | – | SM1+CCRT | 0.24 (0.03, 1.42) | 1.16 (0.14, 9.50) |
| 2.58 (0.50, 18.09) | 1.07 (0.27, 5.15) | 3.76 (0.28, 40.25) | 3.98 (0.71, 29.97) | 6.56 (0.44, 90.59) | 3.35 (0.24, 37.54) | – | XAP + CCRT | 4.73 (0.62, 46.71) |
| 0.38 (0.06, 4.26) | 7.2 (1.10, 48.54) | 0.55 (0.04, 8.31) | 0.58 (0.08, 7.12) | 0.97 (0.06, 18.09) | 0.49 (0.03, 7.91) | – | 0.15 (0.01, 1.81) | SM2+CCRT |
The differences between the compared groups were deemed as significant when the 95% CI of the OR did not contain 1.00, which is marked as bold font. AD, Aidi injection; CCRT, concurrent chemoradiotherapy; CKS, Compound Kushen injection; KA, Kangai injection; KLT, Kanglaite injection; SM1, Shengmai injection; SM2, Shenmai injection; SQFZ, Shenqifuzheng injection; XAP, Xiaoaiping injection. Bold font described significant difference.